Lifecore Biomedical, Inc. De (LFCR) EBT Margin (2010 - 2025)

Lifecore Biomedical's EBT Margin history runs 16 years deep, the most recent figure standing at 3.06% for Q2 2025.

• In Q2 2025, EBT Margin rose 1580.0% year-over-year to 3.06%; the TTM figure through May 2025 stood at 30.01% (down 3743.0% YoY), while the FY2025 annual figure was 30.01%, down 3743.0% from the prior year.
• EBT Margin was 3.06% for Q2 2025 at Lifecore Biomedical, up from 42.04% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 47.02% in Q4 2023 to a low of 118.05% in Q2 2023.
• Historically, EBT Margin has averaged 26.45% across 5 years, with a median of 24.81% in 2022.
• The sharpest annual moves came in 2023 and 2024: EBT Margin sank 10330 bps in 2023, then jumped 9920 bps in 2024.
• A 5-year view of EBT Margin shows it stood at 4.97% in 2021, then slumped by 947 bps to 42.06% in 2022, then jumped by 212 bps to 47.02% in 2023, then sank by 143 bps to 20.05% in 2024, then soared by 85 bps to 3.06% in 2025.
• The last three EBT Margin figures came in at 3.06% (Q2 2025), 42.04% (Q1 2025), and 20.05% (Q4 2024), per Business Quant data.